MENU
+Compare
VANI
Stock ticker: NASDAQ
AS OF
Dec 18, 04:59 PM (EDT)
Price
$1.21
Change
-$0.09 (-6.92%)
Capitalization
71.97M

VANI Vivani Medical Forecast, Technical & Fundamental Analysis

Industry Biotechnology
VANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for VANI with price predictions
Dec 17, 2024

VANI's Stochastic Oscillator is sitting in oversold zone for 8 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VANI advanced for three days, in of 209 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 94 cases where VANI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for VANI moved out of overbought territory on November 29, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on December 09, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on VANI as a result. In of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for VANI turned negative on December 05, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VANI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VANI broke above its upper Bollinger Band on November 13, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.926) is normal, around the industry mean (14.664). P/E Ratio (0.000) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). VANI has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (260.687).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VANI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VANI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
VANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

VANI is expected to report earnings to -10 cents per share on March 27

Vivani Medical VANI Stock Earnings Reports
Q4'24
Est.
$-0.11
Q3'24
Missed
by $0.01
Q2'24
Beat
by $0.02
Q1'24
Beat
by $0.02
Q4'23
Beat
by $0.02
The last earnings report on November 13 showed earnings per share of -10 cents, missing the estimate of -10 cents. With 185.88K shares outstanding, the current market capitalization sits at 71.97M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1350 S. Loop Road
Phone
+1 415 506-8462
Employees
44
Web
https://www.vivani.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PSNL3.840.13
+3.50%
Personalis
TMO528.84-1.42
-0.27%
Thermo Fisher Scientific
BFH65.11-1.23
-1.85%
Bread Financial Holdings
JAZZ122.49-2.71
-2.16%
Jazz Pharmaceuticals plc
MXCT4.27-0.12
-2.73%
MaxCyte

VANI and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VANI has been loosely correlated with VTVT. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if VANI jumps, then VTVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VANI
1D Price
Change %
VANI100%
-1.52%
VTVT - VANI
56%
Loosely correlated
+0.19%
TGTX - VANI
36%
Loosely correlated
-2.41%
ADIL - VANI
36%
Loosely correlated
+3.20%
AXSM - VANI
36%
Loosely correlated
+4.27%
SNPX - VANI
35%
Loosely correlated
-1.99%
More